XML 31 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Tables)
6 Months Ended
Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Schedule of milestone payments

  Milestones  Payments 
       
  (1) filing of a New Drug Application (“NDA”) or regulatory approval for each licensed product  $750,000 
  (2) upon the receipt of regulatory approval from the U.S. FDA for each licensed product   1,750,000